Topic: oversight

Report: FDA safety monitoring, public alerts lacking

The FDA's oversight of drugs doesn't end once they hit the market--or at least, it isn't supposed to. It has an early warning system in place to spot safety issues. Problem is, regulators are struggling to keep up--and falling behind on alerting the public in the process.